Research has shown that by downregulating Ang II expression, propranolol inhibits proliferation and induces apoptosis in human hemangioma endothelial cells (HemECs) via the Protein Kinase B (PKB, also known as AKT) pathway. Here, AKT1 is linked to hemangioma.